• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


2.651 EUR 0.013 0.49%

As of 14:39:30 ET on 01/26/2015.

Snapshot for Vericel Corp (ATQP)

Open: 2.672 Day's Range: 2.636 - 2.715 Volume: 0
Previous Close: 2.664 52wk Range: 2.001 - 4.920 1-Yr Rtn: +0.30%

Stock Chart for ATQP

No chart data available.
  • ATQP:GR 2.715
  • 1D
  • 1M
  • 1Y
Interactive ATQP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATQP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.6170
Est. PEG Ratio -
Market Cap (M EUR) 63.06
Shares Outstanding (M) 23.79
30 Day Average Volume 137
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATQP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATQP

Vericel Corp develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (TRC) adult stem cell technology. The Company's products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient.

Dominick C Colangelo "Nick"Pres/CEO/Chief Acctg OfficerDaniel Orlando "Dan"Chief Operating Officer
Ross TuboChief Scientific OfficerDavid ReckerChief Medical Officer
More Company Profile & Key Executives for ATQP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil